Abstract
ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (1307)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have